pharma · Inflammatory Bowel Disease (IBD) · Melanoma · IRON
Disc Medicine
Disc Medicine clinical programs — 106 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 321 Arsenal St., Suite 101, Watertown, Massachusetts 02472-5710, US
- Employees
- 165
- Programs
- 308
- Drugs
- 442
- Patents
- 706
Disc Medicine projects
106 ClinicalTrials.gov programs sponsored by Disc Medicine.
Disc Medicine has 106 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
Tecentriq 1 200 mg concentrate for solution for infusion
Disc Medicine
(Diffuse) Large B-cell Lymphoma
1 trial -
Tiragolumab for HNSCC, metastatic deficient mis…
Disc Medicine
HNSCC, metastatic deficient mismatch repair (dMMR)/MSI-high (MSI-H) tumors, irresectable or metastatic melanoma, locally advanced or metastatic solid tumor
1 trial -
YERVOY for castration-resistant prostate c…
Disc Medicine
castration-resistant prostate cancer
1 trial -
Zr89
Disc Medicine
giant cell arteritis, rheumatoid arthritis
1 trial -
[18F]Fluor-PEG-Folate
Disc Medicine
giant cell arteritis
1 trial -
[18F]Tetrafluoroborate
Disc Medicine
Differentiated Thyroid Cancer
1 trial -
[68Ga]FAPI-46
Disc Medicine
giant cell arteritis - polymyalgia rheumatica spectrum disease
1 trial -
[68Ga]Ga-PentixaFor
Disc Medicine
Cardiac Sarcoidosis
1 trial -
cRGD-ZW800-1
Disc Medicine
Oral cancer
1 trial -
cRGD-ZW800-1
Disc Medicine
Squamous cell carcinoma of the larynx and hypopharynx
1 trial
Frequently asked questions
How many clinical projects does Disc Medicine have?
106 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.